User:Mcspiritt/TransCelerate BioPharm

Introduction

Mission
TransCelerate BioPharma will develop shared industry research and development solutions to simplify and accelerate the delivery of innovative products to patients. Our non-profit, procompetitive model will be based on a results-oriented approach, emphasizing increased quality in clinical studies and improved patient safety, enabled by broad participation and collaboration across the global research and development community.

Initiatives

 * Risk Based Monitoring
 * Shared Investigator Portal
 * Site Qualification and Training
 * Data Standards
 * Comparator Drugs

Leadership

 * Dalvir Gill, PhD, is the Chief Executive Officer of TransCelerate and serves on its Board of Directors.

Board of Directors

 * Sef Kurstjens - Astellas - CMO & President Pharma Global Development


 * Briggs Morrison - AstraZeneca - EVP, Global Medicines Development


 * Garry Neil (Chairman of the Board) - Braeburn Pharmaceuticals - Head of R&D


 * Brian Daniels - Bristol-Myers Squibb - SVP Global Development & Medical Affairs


 * TBC - Biogen Idec


 * Klaus Dugi - Boehinger Ingleheim - Corporate SVP, Medicines


 * Annalisa Jenkins - EMD Serono - Head of Global Development & Medical


 * Marco Taglietti - Forest Laboratories, Inc. - President of Forest Research Institute & CMO


 * Patrick Vallance - GlaxoSmithKline - President Pharmaceuticals R&D


 * Paul Stoffels - Johnson & Johnson - CSO, Worldwide Chairman of the Pharmaceuticals


 * Pablo Cagnoni - Onyx Pharmaceuticals - EVP, Global Head of R&D


 * Jan Lundberg - Eli Lilly & Co. - EVP of Science and Technology


 * John Hubbard - Pfizer - Senior Vice President, Head of Development Operations


 * Corsee Sanders - Roche - Global Head of Development Innovation & Clinical Operations


 * Elias Zerhouni - Sanofi - President of Global R&D


 * Dalvir Gill - TransCelerate BioPharma Inc. - Chief Executive Officer

Member Companies

 * Abbott
 * Astellas Pharma Inc
 * AstraZeneca
 * Biogen Idec
 * Boehringer Ingelheim
 * Braeburn Pharmaceuticals
 * Bristol-Myers Squibb
 * Eli Lilly and Company
 * EMD Serono, Inc.
 * Forest Research Institute
 * GlaxoSmithKline
 * Johnson & Johnson
 * Onyx Pharmaceuticals
 * Pfizer
 * Roche
 * Sanofi